Abstract
The main challenge in the management of Takayasu's arteritis (TA) consists in evaluating if the patient is in disease activity, once new lesions occur in patients without any clinical or laboratory manifestation. Recent studies ascribe the disease's physiopathology to Th1 and Th17 pathways and its related cytokines. The new hybrid positron-emission tomography/magnetic resonance imaging (P…